These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Toward personalized medicine in the neuropsychiatric field. Wong EH; Fox JC; Ng MY; Lee CM Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858 [TBL] [Abstract][Full Text] [Related]
66. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice. Squassina A; Manchia M; Manolopoulos VG; Artac M; Lappa-Manakou C; Karkabouna S; Mitropoulos K; Del Zompo M; Patrinos GP Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531 [TBL] [Abstract][Full Text] [Related]
67. Can pharmacogenetics help rescue drugs withdrawn from the market? Shah RR Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848 [TBL] [Abstract][Full Text] [Related]
68. [Importance of pharmacogenetics]. Bolhuis PA Ned Tijdschr Geneeskd; 2001 Jan; 145(1):15-8. PubMed ID: 11198959 [TBL] [Abstract][Full Text] [Related]
69. Drug discovery and development in the age of molecular medicine. Vallance P; Levick M Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574 [TBL] [Abstract][Full Text] [Related]
70. Clinically available pharmacogenomics tests. Flockhart DA; Skaar T; Berlin DS; Klein TE; Nguyen AT Clin Pharmacol Ther; 2009 Jul; 86(1):109-13. PubMed ID: 19369936 [TBL] [Abstract][Full Text] [Related]
71. Pharmacogenetics in drug discovery and development: a translational perspective. Roses AD Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753 [TBL] [Abstract][Full Text] [Related]
72. Evolution of pharmacogenomics. Somogy A Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663 [TBL] [Abstract][Full Text] [Related]
73. SNPs and haplotypes: genetic markers for disease and drug response (review). Shastry BS Int J Mol Med; 2003 Mar; 11(3):379-82. PubMed ID: 12579344 [TBL] [Abstract][Full Text] [Related]
74. Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group. Bromley CM; Close S; Cohen N; Favis R; Fijal B; Gheyas F; Liu W; Lopez-Correa C; Prokop A; Singer JB; Snapir A; Tchelet A; Wang D; Goldstaub D; Pharmacogenomics J; 2009 Feb; 9(1):14-22. PubMed ID: 18794908 [TBL] [Abstract][Full Text] [Related]
76. Novel technology and the development of pharmacogenetics within the pharmaceutical industry. Gibson N; Jawaid A; March R Pharmacogenomics; 2005 Jun; 6(4):339-56. PubMed ID: 16004553 [TBL] [Abstract][Full Text] [Related]
77. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341 [TBL] [Abstract][Full Text] [Related]
78. Pharmacogenetic considerations in the treatment of psychiatric disorders. Lohoff FW; Ferraro TN Expert Opin Pharmacother; 2010 Feb; 11(3):423-39. PubMed ID: 20102306 [TBL] [Abstract][Full Text] [Related]